Literature DB >> 28318681

Updated recommendations on the use of hydroxychloroquine in dermatologic practice.

Anthony P Fernandez1.   

Abstract

Hydroxychloroquine has unique immunomodulatory properties and an attractive adverse effect profile. Over the past 10 years, research has led to significant updates in clinical recommendations concerning the optimal use of hydroxychloroquine and monitoring of patients taking it. We discuss updated recommendations concerning hydroxychloroquine daily dosing, retinopathy screening, serologic monitoring, use in smokers, use in pregnant women, and adverse effect risk and monitoring. This review can hopefully serve as an aid to dermatologists and help ensure they continue using hydroxychloroquine safely and effectively.
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse effects; hydroxychloroquine; lupus erythematosus; monitoring; recommendations; retinopathy screening; whole blood levels

Mesh:

Substances:

Year:  2017        PMID: 28318681     DOI: 10.1016/j.jaad.2017.01.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  [Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.

Authors:  D Morgado-Carrasco; J Ibaceta-Ayala; J Piquero-Casals
Journal:  Actas Dermosifiliogr       Date:  2022-02

2.  The efficacy of antimalarial drugs in the therapy of selected forms of cicatricial alopecia.

Authors:  Martyna A Zbiciak-Nylec; Ligia Brzezińska-Wcisło; Natalia Salwowska
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

3.  Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.

Authors:  Anagha Bangalore Kumar; Elizabeth K Blixt; Lisa A Drage; Rokea A El-Azhary; David A Wetter
Journal:  J Am Acad Dermatol       Date:  2019-01-29       Impact factor: 11.527

4.  [Skin manifestations associated with the new coronavirus SARS-CoV-2 disease].

Authors:  Áurea Redondo-Sendino; Isabel Cristina González Sánchez; Beatriz de Victoria Fernández
Journal:  Med Clin (Barc)       Date:  2020-07-24       Impact factor: 1.725

5.  Dermatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study.

Authors:  Nouf Talal Mleeh; Nujood Abdulwahed Alzahrani; Jehad Osama Hariri; Hatan Hisham Mortada; Mohammed Ridha Algethami
Journal:  Interact J Med Res       Date:  2019-12-19

Review 6.  Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.

Authors:  Jasmine Chang; Leila Cattelan; Moshe Ben-Shoshan; Michelle Le; Elena Netchiporouk
Journal:  J Asthma Allergy       Date:  2021-03-09

7.  [Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome: a case report].

Authors:  Ansumana Mohammed Keita; Mouna Zahlane; Laila Benjilali; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2021-03-18

8.  Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.

Authors:  Ruben Jauregui; Rait Parmann; Yan Nuzbrokh; Stephen H Tsang; Janet R Sparrow
Journal:  Transl Vis Sci Technol       Date:  2020-08-05       Impact factor: 3.283

9.  Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.

Authors:  Áurea Redondo-Sendino; Isabel Cristina González Sánchez; Beatriz de Victoria Fernández
Journal:  Med Clin (Engl Ed)       Date:  2020-10-08

10.  [Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].

Authors:  D Morgado-Carrasco; J Ibaceta-Ayala; J Piquero-Casals
Journal:  Actas Dermosifiliogr       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.